We are looking for children age 15-17 with Type 1 diabetes for a research study. The purpose of this study is to find out if a medicine called liraglutide can help control blood sugar in adolescents with Type 1 diabetes. This drug is approved by the Food and Drug Administration for the treatment of Type 2 diabetes and obesity in adults. Read More
Diagnosed with Type 1 diabetes for at least 1 year.
Wear an insulin pump and continuous glucose monitor to manage diabetes.
Are not pregnant or planning to become pregnant.
Do not have a history of acute pancreatitis.
Have not used liraglutide in the past.
We are looking for children age 7+ and adults with Type 1 diabetes for a research study. The purpose of this study is to learn more about how the timing of when insulin is taken and the size of meals affects glucose levels. Read More
Age 7+ (children) and age 18+ (adults).
Diagnosed with Type 1 diabetes.
Treated with multiple daily injection therapy or insulin pump.
This study enrolls select toddlers who were born at Oishei Children's Hospital. We will use the same tests to assess kids born at full-term as are given to preterm babies (preemies), so that we can see how their development compares. Read More
Children ages 1-2 years (22-26 months).
Born at Oishei Children's Hospital.
Have been randomly selected and contacted by our team
This study enrolls babies with neonatal opioid withdrawal syndrome (NOWS). The purpose of this study is to learn about how babies with this syndrome grow and develop. This will help us learn the best way to care for babies with NOWS. Read More
Infants born at 36 weeks gestation or greater
Managed for NOWS at Oishei Children's Hospital
This study enrolls children ages 4-13 who have amblyopia ("lazy eye"). The purpose of the study is to learn if vision is improved by playing a binocular game while wearing corrective glasses. Read More
Children ages 4-13.
Diagnosed with amblyopia, also known as "lazy eye."
This study enrolls newborn infants with treatable retinopathy of prematurity (ROP). ROP is is one of the leading causes of childhood blindness worldwide. The purpose of this study is to learn if aflibercept (Eyelea) works to treat this condition. Read More
Children (newborn infants).
Gestational age at birth must be 32 weeks or less, birth weight must be 1500g or less
Must have retinopathy of prematurity (ROP) that has not yet been treated.
Must weigh at least 800 g
The purpose of the study is to learn about the safety and efficacy of a medication called TransCon CNP in children ages 2-10 with achondroplasia. Children with achondroplasia lack this compound which is instrumental in promoting growth and ameliorating other potential medical problems. Read More
Children ages 2-10 (inclusive).
Have a clinical diagnosis of ACH with genetic confirmation
Have not entered puberty yet.
Able to stand without assistance.
Caregiver willing and able to administer subcutaneous (under the skin) injections of study drug.
This study enrolls infants who are admitted to Oishei Children's hospital's Pediatric Intensive Care Unit (PICU) with bronchiolitis. The purpose of this study is to see how a medication for the condition compares with usual care. Read More
Children (infants) less than 8 months of age.
Admitted to PICU with bronchiolitis.
This study enrolls people ages 12 and up with Cystic Fibrosis. The purpose of this study is to give people access to a treatment for a specific type of CF when they have a critical need for it. Read More
Children and adults ages 12+.
Confirmed diagnosis of CF.
Contact the study team to learn about other eligibility criteria.